On NSE, shares of the company zoomed 17.88 per cent to close at Rs 148.60.
The company's market valuation went up by Rs 1,152.54 crore to Rs 7,691.54 crore.
On the equity volume front, 96.87 lakh shares of the company were traded on BSE and over 8 crore shares changed hands on NSE during the day.
BSE had sought clarification from Fortis Healthcare with reference to reports that Manipal hospital is in advanced talks to merge Fortis Health with itself.
In a clarification to BSE, Fortis Healthcare later said, "The company is still evaluating the best possible way to raise the fund and no firm decision in this regard has been approved by the Board till date. We will keep the stock exchanges updated/informed."
The filing further added that the company in the past informed the stock exchanges about fund raising options of up to Rs 5,000 crore.
Fortis Healthcare Ltd today said its wholly-owned arm Fortis Hospitals had deployed funds to the tune of Rs 473 crore as secured short-term investments to group firms of its promoters, billionaire Singh brothers.
Responding to a report by Bloomberg, which said "Singh brothers took at least 5 billion rupees ($78 million) out of the publicly-traded hospital company they control without board approval about a year ago", Fortis Healthcare said the loans are adequately secured and repayment has since commenced as per agreed payment schedule.
The report citing unnamed sources had stated the company's auditor, Deloitte Haskins & Sells LLP had "refused to sign off on the company's second-quarter results until the funds were accounted for or returned".
However, the healthcare chain refuted the allegations.
"We categorically deny the allegations that 'Auditors have Refused to Sign the Accounts for Q2'. The results for the Q2 could not be tabled before the Board for approval and the same was communicated to the stock exchanges on November 14, 2017," it said.
Yesterday, the company informed stock exchanges that the Singh brothers had resigned as directors from the company's board following the Delhi High Court order upholding the Rs 3,500 crore arbitral award in favour of Daiichi Sankyo.
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.